Literature DB >> 25661126

Demographics of patients having cataract surgery after laser in situ keratomileusis.

Kei Iijima1, Kazutaka Kamiya2, Kimiya Shimizu1, Akihito Igarashi1, Mari Komatsu1.   

Abstract

PURPOSE: To retrospectively assess the demographics of patients having cataract surgery in eyes with previous laser in situ keratomileusis (LASIK).
SETTING: Department of Ophthalmology, Kitasato University, Kanagawa, and Sanno Hospital, Tokyo, Japan.
DESIGN: Retrospective case series.
METHODS: This study evaluated eyes of consecutive patients scheduled for cataract surgery after previous LASIK (Group 1). The control groups comprised eyes with axial lengths (ALs) matched with ALS in Group 1 (Group 2) and all eyes scheduled for cataract surgery (Group 3). Assessed were age, sex, corrected distance visual acuity, manifest refraction, keratometry (K) readings, corneal astigmatism, and corneal higher-order aberrations (HOAs).
RESULTS: Group 1 comprised 40 eyes of 40 patients; Group 2, 606 eyes of 606 patients; and Group 3, 3642 eyes of 3642 patients. The mean age at cataract surgery of patients in Group 1 was 54.6 years ± 8.1 (SD), which was significantly younger than in Group 2 (by approximately 10 years) and Group 3 (by approximately 15 years) (P < .001, Student t test). In Group 1, 70.0% of patients were men, a significantly higher percentage than in Groups 2 and 3 (P < .05, Fisher exact test). The rate of corneal HOAs was significantly higher in Group 1 than in Groups 2 and 3 (P < .05, Student t test). There were no significant differences in other demographics except in K readings.
CONCLUSION: A long AL and an increase in corneal HOAs might contribute to a tendency for cataract surgery to be performed earlier in eyes in which LASIK has been performed. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25661126     DOI: 10.1016/j.jcrs.2014.05.045

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  Trifocal diffractive intraocular lens implantation in patients after previous corneal refractive laser surgery for myopia.

Authors:  Qiu-Mei Li; Feng Wang; Zhe-Ming Wu; Zhen Liu; Chuan Zhan; Bing-Heng Chen; Jing Sima; Knut Stieger; Shao-Wei Li
Journal:  BMC Ophthalmol       Date:  2020-07-17       Impact factor: 2.209

Review 2.  Meta-analysis and review: effectiveness, safety, and central port design of the intraocular collamer lens.

Authors:  Mark Packer
Journal:  Clin Ophthalmol       Date:  2016-06-09

3.  Visual Outcomes, Quality of Vision, and Quality of Life of Diffractive Multifocal Intraocular Lens Implantation after Myopic Laser In Situ Keratomileusis: A Prospective, Observational Case Series.

Authors:  John S M Chang; Jack C M Ng; Vincent K C Chan; Antony K P Law
Journal:  J Ophthalmol       Date:  2017-01-04       Impact factor: 1.909

4.  Clinical outcomes with distance-dominant multifocal and monofocal intraocular lenses in post-LASIK cataract surgery planned using an intraoperative aberrometer.

Authors:  Bret Fisher; Rick Potvin
Journal:  Clin Exp Ophthalmol       Date:  2018-02-23       Impact factor: 4.207

5.  Femtosecond laser-assisted cataract surgery with implantation of a diffractive trifocal intraocular lens after laser in situ keratomileusis: a case report.

Authors:  Wei Wang; Shuang Ni; Xi Li; Xiang Chen; Yanan Zhu; Wen Xu
Journal:  BMC Ophthalmol       Date:  2018-07-03       Impact factor: 2.209

6.  Clinical Characteristics of Presenile Cataract: Change over 10 Years in Southern Taiwan.

Authors:  Hun-Ju Yu; Ming-Tse Kuo; Pei-Chang Wu
Journal:  Biomed Res Int       Date:  2021-03-20       Impact factor: 3.411

7.  Outcomes of a Management Strategy in Eyes with Corneal Irregularity and Cataract.

Authors:  Mathew Kurian Kummelil; Rohit Shetty; Luci Kaweri; Shama Shaligram; Mukesh Paryani
Journal:  Biomed Res Int       Date:  2016-08-03       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.